| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $351,439,783 | 169 | 100 |
| Chapman Rowan E | director | 0 | $0 | 4 | $1.76M | $-1.76M |
| Marcus Gail Boxer | director | 0 | $0 | 2 | $2.41M | $-2.41M |
| Baynes Roy D. | director | 0 | $0 | 2 | $2.81M | $-2.81M |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | 0 | $0 | 16 | $9.93M | $-9.93M |
| ROSENMAN HERM | director | 0 | $0 | 2 | $15.14M | $-15.14M |
| BOTHA ROELOF | director | 0 | $0 | 1 | $17.71M | $-17.71M |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 0 | $0 | 22 | $23.69M | $-23.69M |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | 0 | $0 | 17 | $23.91M | $-23.91M |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 0 | $0 | 26 | $24.07M | $-24.07M |
| Sheena Jonathan | CO-FOUNDER | 0 | $0 | 42 | $31.83M | $-31.83M |
| Chapman Steven Leonard | CEO AND PRESIDENT | 0 | $0 | 21 | $91.68M | $-91.68M |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | 0 | $0 | 19 | $143.48M | $-143.48M |
Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify single-gene disorders by screening for specific single-gene mutations. Horizon, a comprehensive carrier screening test to determine an individual's …
Over the last 12 months, insiders at Natera, Inc. have bought $0 and sold $351.44M worth of Natera, Inc. stock.
On average, over the past 5 years, insiders at Natera, Inc. have bought $7.68M and sold $148.7M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 219,820 shares for transaction amount of $6.32M was made by Rabinowitz Matthew () on 2022‑05‑12.
| 2026-10-30 | Sale | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 1,906 0.0014% | $425.55 | $811,098 | -7.37% | |
| 2026-10-28 | Sale | Sheena Jonathan | CO-FOUNDER | 187 0.0001% | $426.34 | $79,726 | -5.41% | |
| 2026-10-28 | Sale | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | 898 0.0006% | $426.34 | $382,854 | -5.41% | |
| 2026-10-28 | Sale | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | 968 0.0007% | $426.34 | $412,698 | -5.41% | |
| 2026-10-28 | Sale | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 1,162 0.0008% | $426.34 | $495,408 | -5.41% | |
| 2026-10-28 | Sale | Chapman Steven Leonard | CEO AND PRESIDENT | 3,430 0.0024% | $426.34 | $1.46M | -5.41% | |
| 2026-10-28 | Sale | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 1,198 0.0008% | $426.34 | $510,756 | -5.41% | |
| 2026-10-28 | Sale | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 2,376 0.0017% | $426.40 | $1.01M | -5.41% | |
| 2026-10-28 | Sale | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 1,178 0.0008% | $426.46 | $502,372 | ||
| 2026-10-27 | Sale | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | 1,718 0.0012% | $406.00 | $697,508 | +0.85% | |
| 2026-10-27 | Sale | Sheena Jonathan | CO-FOUNDER | 291 0.0002% | $406.00 | $118,146 | +0.85% | |
| 2026-10-27 | Sale | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | 781 0.0005% | $406.00 | $317,086 | +0.85% | |
| 2026-10-27 | Sale | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | 884 0.0006% | $406.00 | $358,904 | +0.85% | |
| 2026-10-27 | Sale | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 1,010 0.0007% | $406.00 | $410,060 | +0.85% | |
| 2026-10-27 | Sale | Chapman Steven Leonard | CEO AND PRESIDENT | 2,264 0.0016% | $406.00 | $919,184 | +0.85% | |
| 2026-10-27 | Sale | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 781 0.0005% | $406.00 | $317,086 | +0.85% | |
| 2026-10-21 | Sale | Sheena Jonathan | CO-FOUNDER | 1,162 0.0008% | $407.96 | $474,045 | -2.05% | |
| 2026-10-21 | Sale | Sheena Jonathan | CO-FOUNDER | 3,150 0.0022% | $410.55 | $1.29M | -2.05% | |
| 2026-10-16 | Sale | Sheena Jonathan | CO-FOUNDER | 697 0.0005% | $399.99 | $278,796 | +3.04% | |
| 2026-10-16 | Sale | Sheena Jonathan | CO-FOUNDER | 1,500 0.0011% | $402.47 | $603,710 | +3.04% |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | 2117676 1.4691% | $822.99M | 1 | 104 | +52.44% |
| BOTHA ROELOF | director | 1154198 0.8007% | $448.56M | 2 | 3 | +4.55% |
| HEALY JAMES | director | 0 0% | $0 | 3 | 2 | <0.0001% |
| Steuart John | director | 0 0% | $0 | 1 | 1 | <0.0001% |
$13,470,814 | 657 | -0.42% | $35.64M | |
$78,162,120 | 207 | 10.26% | $241.09M | |
Natera, Inc. (NTRA) | $26,663,659 | 7 | -12.13% | $56.02B |
$66,999 | 2 | -47.60% | $5.87M | |
$99,997 | 1 | -77.35% | $20.04M |
| Increased Positions | 466 | +65.73% | 15M | +11.64% |
| Decreased Positions | 312 | -44.01% | 13M | -10.14% |
| New Positions | 178 | New | 2M | New |
| Sold Out Positions | 62 | Sold Out | 2M | Sold Out |
| Total Postitions | 863 | +21.72% | 132M | +1.5% |
| Vanguard Group Inc | $2.84M | 8.98% | 12.39M | -287,620 | -2.27% | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $2.73M | 8.66% | 11.95M | -240,401 | -1.97% | 2025-09-30 |
| Jpmorgan Chase & Co | $2.66M | 8.43% | 11.63M | +1M | +9.44% | 2025-09-30 |
| Blackrock, Inc. | $2.51M | 7.95% | 10.96M | +7,636 | +0.07% | 2025-09-30 |
| Farallon Capital Management Llc | $973,360.00 | 3.08% | 4.25M | -568,357 | -11.79% | 2025-09-30 |
| State Street Corp | $775,676.00 | 2.46% | 3.39M | +72,087 | +2.17% | 2025-09-30 |
| Duquesne Family Office Llc | $735,614.00 | 2.33% | 3.21M | +129,342 | +4.19% | 2025-09-30 |
| Franklin Resources Inc | $609,862.00 | 1.93% | 2.67M | +727,366 | +37.54% | 2025-09-30 |
| Geode Capital Management, Llc | $594,287.00 | 1.88% | 2.6M | +44,230 | +1.73% | 2025-09-30 |
| Wellington Management Group Llp | $584,929.00 | 1.85% | 2.56M | -77,630 | -2.95% | 2025-09-30 |